TP53 and hepatocellular carcinoma: Of all clinical and molecular characteristics regarded as the de novo HCC cohort, higher grade T classification (T>0), higher grade of stage and ARID1A, TP53 mutations and genetic alterations of any m6A genes were associated with poorer OS in univariate Cox analysis significantly (Table S5).